Sun Pharma subsidiary gets USFDA nod for anti-hypertension drug

19 Nov 2009 Evaluate

Drug firm Sun Pharmaceutical Industries subsidiary has received US Drug regulator USFDA approval for anti-hypertension drug yesterday. The anti hyper tension drug is Nicardipine Hydrochloride injections, that will be available in the strength of 25 mg/10ml. The injections are used for short-term treatment of hypertension when oral therapy is not feasible.

crackcrack

Sun Pharma Inds. Share Price

1717.50 -1.70 (-0.10%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×